MNLO

Menlo Therapeutics Inc.CIK 1566044 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for MNLO PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for MNLO

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
BARBARI SHARON SURREY	Director	5	$0	$0	2020-08-20
Sandoval Elisabeth	Director	4	$0	$0	2020-08-03
Basta Steven L	See Remarks	18	$0	$0	2020-08-03
Bruno Anthony D	Director	6	$0	$0	2020-08-03
Bright Rex	Director	7	$0	$0	2020-08-03
Wiley Matthew T.	Chief Commercial Officer	11	$0	$0	2020-06-30
Harsch Mutya	Chief Legal Officer and GC	12	$0	$0	2020-06-30
Domzalski David	President and CEO	17	$0	$0	2020-06-30
Stuart Iain	Chief Scientific Officer	14	$0	$0	2020-06-30
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD	10% Owner	1	$5.00M	$0	2020-06-09
Saik Andrew	Chief Financial Officer	4	$0	$0	2020-05-06
Hirsch Stanley	Director	9	$0	$0	2020-04-03
Hadar Ilan	CFO and Country Manager	12	$0	$0	2020-03-09
Kwon Paul	See Remarks	9	$0	$0	2019-12-11
Krasnow Ronald A.	See Remarks	5	$0	$0	2019-12-11
BALL KRISTINE M	See Remarks	9	$0	$0	2019-12-11
Ebel Ted	Director	2	$0	$0	2019-06-25
Royston Aaron	Director	2	$0	$0	2019-06-25
Whitcup Scott M	Director	3	$0	$0	2019-06-25
MCGIRR DAVID W J	Director	2	$0	$0	2019-06-25
BERNS PAUL L	Director	2	$0	$0	2019-06-25
Spellman Mary	Chief Medical Officer	1	$0	$0	2018-12-10
Watson James F	Other	2	$0	$3.83M	2018-07-24
Presidio Partners 2007 (Parallel), L.P.	10% Owner	1	$0	$0	2018-03-02
FMR LLC	Other	4	$0	$0	2018-01-29
venBio Global Strategic Fund II L.P.	10% Owner	3	$4.50M	$0	2018-01-29
Remeditex Ventures LLC	10% Owner	7	$1.70M	$0	2018-01-29
Vivo Capital Fund VIII, L.P.	10% Owner	10	$5.00M	$0	2018-01-29
Cha Albert	Director	10	$5.00M	$0	2018-01-29
Collier David J	10% Owner	12	$0	$0	2018-01-29

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
BARBARI SHARON	Director	M Exercise deriv	2020-08-20	2020-08-21	75,000	—	$0	13,971	SEC↗
BARBARI SHARON	Director	M Exercise	2020-08-20	2020-08-21	75,000	$1.48	$111.0K	75,000	SEC↗
BARBARI SHARON	Director	A Award deriv	2020-08-03	2020-08-05	22,500	—	$0	22,500	SEC↗
Basta Steven L	Director	A Award deriv	2020-08-03	2020-08-05	22,500	—	$0	22,500	SEC↗
Bruno Anthony D	Director	A Award deriv	2020-08-03	2020-08-05	22,500	—	$0	22,500	SEC↗
Sandoval Elisabeth	Director	A Award deriv	2020-08-03	2020-08-05	22,500	—	$0	22,500	SEC↗
Bright Rex	Director	A Award deriv	2020-08-03	2020-08-05	22,500	—	$0	22,500	SEC↗
Domzalski David	President and CEO	F Tax w/h	2020-06-30	2020-07-02	6,239	$1.73	$10.8K	1,240,966	SEC↗
Harsch Mutya	Chief Legal Officer and GC	F Tax w/h	2020-06-30	2020-07-02	1,822	$1.73	$3.2K	318,887	SEC↗
Stuart Iain	Chief Scientific Officer	F Tax w/h	2020-06-30	2020-07-02	2,378	$1.73	$4.1K	291,018	SEC↗
Wiley Matthew T.	Chief Commercial Officer	F Tax w/h	2020-06-30	2020-07-02	1,541	$1.73	$2.7K	352,425	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	P Buy	2020-06-09	2020-06-11	2,702,702	$1.85	$5.00M	22,876,410	SEC↗
Domzalski David	President and CEO	A Award deriv	2020-05-06	2020-05-08	680,000	—	$0	680,000	SEC↗
Harsch Mutya	Chief Legal Officer and GC	A Award deriv	2020-05-06	2020-05-08	150,000	—	$0	150,000	SEC↗
Saik Andrew	Chief Financial Officer	A Award deriv	2020-05-06	2020-05-08	250,000	—	$0	250,000	SEC↗
Stuart Iain	Chief Scientific Officer	A Award deriv	2020-05-06	2020-05-08	112,500	—	$0	112,500	SEC↗
Wiley Matthew T.	Chief Commercial Officer	A Award deriv	2020-05-06	2020-05-08	150,000	—	$0	150,000	SEC↗
Domzalski David	President and CEO	A Award	2020-05-06	2020-05-08	680,000	—	$0	1,247,213	SEC↗
Harsch Mutya	Chief Legal Officer and GC	A Award	2020-05-06	2020-05-08	150,000	—	$0	320,712	SEC↗
Saik Andrew	Chief Financial Officer	A Award	2020-05-06	2020-05-08	250,000	—	$0	300,000	SEC↗
Stuart Iain	Chief Scientific Officer	A Award	2020-05-06	2020-05-08	112,500	—	$0	293,401	SEC↗
Wiley Matthew T.	Chief Commercial Officer	A Award	2020-05-06	2020-05-08	150,000	—	$0	353,967	SEC↗
Domzalski David	President and CEO	F Tax w/h	2020-04-06	2020-04-07	11,772	$1.40	$16.5K	567,213	SEC↗
Harsch Mutya	Chief Legal Officer and GC	F Tax w/h	2020-04-06	2020-04-07	4,474	$1.40	$6.3K	170,712	SEC↗
Stuart Iain	Chief Scientific Officer	F Tax w/h	2020-04-06	2020-04-07	3,763	$1.40	$5.3K	180,901	SEC↗
Wiley Matthew T.	Chief Commercial Officer	F Tax w/h	2020-04-06	2020-04-07	908	$1.40	$1.3K	203,967	SEC↗
Basta Steven L	Director	A Award	2020-04-03	2020-04-07	14,499	—	$0	536,537	SEC↗
Bruno Anthony D	Director	A Award	2020-04-03	2020-04-07	75,690	—	$0	120,123	SEC↗
Bruno Anthony D	Director	A Award	2020-04-03	2020-04-07	14,933	—	$0	135,056	SEC↗
Domzalski David	President and CEO	A Award	2020-04-03	2020-04-07	141,901	—	$0	329,397	SEC↗
Domzalski David	President and CEO	A Award	2020-04-03	2020-04-07	249,588	—	$0	578,985	SEC↗
Harsch Mutya	Chief Legal Officer and GC	A Award	2020-04-03	2020-04-07	92,302	—	$0	175,186	SEC↗
Harsch Mutya	Chief Legal Officer and GC	A Award	2020-04-03	2020-04-07	26,381	—	$0	82,884	SEC↗
Hirsch Stanley	Director	A Award	2020-04-03	2020-04-07	71,303	—	$0	201,410	SEC↗
Hirsch Stanley	Director	A Award	2020-04-03	2020-04-07	220,496	—	$0	328,609	SEC↗
Hirsch Stanley	Director	A Award	2020-04-03	2020-04-07	63,844	—	$0	130,107	SEC↗
Stuart Iain	Chief Scientific Officer	A Award	2020-04-03	2020-04-07	27,530	—	$0	86,982	SEC↗
Stuart Iain	Chief Scientific Officer	A Award	2020-04-03	2020-04-07	97,682	—	$0	184,664	SEC↗
Wiley Matthew T.	Chief Commercial Officer	A Award	2020-04-03	2020-04-07	91,430	—	$0	204,875	SEC↗
Wiley Matthew T.	Chief Commercial Officer	A Award	2020-04-03	2020-04-07	46,394	—	$0	113,445	SEC↗
Domzalski David	President and CEO	F Tax w/h	2020-03-31	2020-04-02	4,456	$2.68	$11.9K	187,496	SEC↗
Stuart Iain	Chief Scientific Officer	F Tax w/h	2020-03-31	2020-04-02	1,940	$2.68	$5.2K	59,452	SEC↗
Wiley Matthew T.	Chief Commercial Officer	F Tax w/h	2020-03-31	2020-04-02	525	$2.68	$1.4K	67,051	SEC↗
Harsch Mutya	Chief Legal Officer and GC	F Tax w/h	2020-03-31	2020-04-02	1,688	$2.68	$4.5K	56,503	SEC↗
Saik Andrew	Chief Financial Officer	A Award deriv	2020-03-23	2020-03-24	100,000	—	$0	100,000	SEC↗
Saik Andrew	Chief Financial Officer	A Award	2020-03-23	2020-03-24	50,000	—	$0	50,000	SEC↗
BARBARI SHARON SURREY	Director	A Award deriv	2020-03-19	2020-03-23	45,000	—	$0	45,000	SEC↗
Basta Steven L	Director	A Award deriv	2020-03-19	2020-03-23	45,000	—	$0	45,000	SEC↗
Bright Rex	Director	A Award deriv	2020-03-19	2020-03-23	45,000	—	$0	45,000	SEC↗
Bruno Anthony D	Director	A Award deriv	2020-03-19	2020-03-23	45,000	—	$0	45,000	SEC↗
Sandoval Elisabeth	Director	A Award deriv	2020-03-19	2020-03-23	45,000	—	$0	45,000	SEC↗
BARBARI SHARON SURREY	Director	A Award deriv	2020-03-09	2020-03-11	29,271	—	$0	29,271	SEC↗
Bright Rex	Director	A Award deriv	2020-03-09	2020-03-11	14,778	—	$0	14,778	SEC↗
Bright Rex	Director	A Award deriv	2020-03-09	2020-03-11	29,271	—	$0	29,271	SEC↗
Bright Rex	Director	A Award deriv	2020-03-09	2020-03-11	22,603	—	$0	22,603	SEC↗
Bright Rex	Director	A Award deriv	2020-03-09	2020-03-11	12,773	—	$0	12,773	SEC↗
Bright Rex	Director	A Award deriv	2020-03-09	2020-03-11	15,994	—	$0	15,994	SEC↗
Domzalski David	President and CEO	A Award deriv	2020-03-09	2020-03-11	42,278	—	$0	42,278	SEC↗
Domzalski David	President and CEO	A Award deriv	2020-03-09	2020-03-11	41,578	—	$0	41,578	SEC↗
Domzalski David	President and CEO	A Award deriv	2020-03-09	2020-03-11	11,107	—	$0	11,107	SEC↗
Domzalski David	President and CEO	A Award deriv	2020-03-09	2020-03-11	140,286	—	$0	140,286	SEC↗
Domzalski David	President and CEO	A Award deriv	2020-03-09	2020-03-11	194,141	—	$0	194,141	SEC↗
Domzalski David	President and CEO	A Award deriv	2020-03-09	2020-03-11	35,544	—	$0	35,544	SEC↗
Domzalski David	President and CEO	A Award deriv	2020-03-09	2020-03-11	101,296	—	$0	101,296	SEC↗
Domzalski David	President and CEO	A Award deriv	2020-03-09	2020-03-11	142,716	—	$0	142,716	SEC↗
Hadar Ilan	CFO and Country Manager	A Award deriv	2020-03-09	2020-03-11	35,774	—	$0	35,774	SEC↗
Hadar Ilan	CFO and Country Manager	A Award deriv	2020-03-09	2020-03-11	116,231	—	$0	116,231	SEC↗
Hadar Ilan	CFO and Country Manager	A Award deriv	2020-03-09	2020-03-11	20,789	—	$0	20,789	SEC↗
Hadar Ilan	CFO and Country Manager	A Award deriv	2020-03-09	2020-03-11	56,275	—	$0	56,275	SEC↗
Hadar Ilan	CFO and Country Manager	A Award deriv	2020-03-09	2020-03-11	3,239	—	$0	3,239	SEC↗
Hadar Ilan	CFO and Country Manager	A Award deriv	2020-03-09	2020-03-11	14,291	—	$0	14,291	SEC↗
Hadar Ilan	CFO and Country Manager	A Award deriv	2020-03-09	2020-03-11	10,663	—	$0	10,663	SEC↗
Hadar Ilan	CFO and Country Manager	A Award deriv	2020-03-09	2020-03-11	119,667	—	$0	119,667	SEC↗
Hadar Ilan	CFO and Country Manager	A Award deriv	2020-03-09	2020-03-11	35,544	—	$0	35,544	SEC↗
Hadar Ilan	CFO and Country Manager	A Award deriv	2020-03-09	2020-03-11	57,086	—	$0	57,086	SEC↗
Harsch Mutya	Chief Legal Officer and GC	A Award deriv	2020-03-09	2020-03-11	57,086	—	$0	57,086	SEC↗
Harsch Mutya	Chief Legal Officer and GC	A Award deriv	2020-03-09	2020-03-11	29,620	—	$0	29,620	SEC↗
Harsch Mutya	Chief Legal Officer and GC	A Award deriv	2020-03-09	2020-03-11	41,643	—	$0	41,643	SEC↗
Hirsch Stanley	Director	A Award deriv	2020-03-09	2020-03-11	15,994	—	$0	15,994	SEC↗
Hirsch Stanley	Director	A Award deriv	2020-03-09	2020-03-11	29,481	—	$0	29,481	SEC↗
Hirsch Stanley	Director	A Award deriv	2020-03-09	2020-03-11	48,667	—	$0	48,667	SEC↗
Stuart Iain	Chief Scientific Officer	A Award deriv	2020-03-09	2020-03-11	17,772	—	$0	17,772	SEC↗
Stuart Iain	Chief Scientific Officer	A Award deriv	2020-03-09	2020-03-11	45,020	—	$0	45,020	SEC↗
Stuart Iain	Chief Scientific Officer	A Award deriv	2020-03-09	2020-03-11	57,086	—	$0	57,086	SEC↗
Stuart Iain	Chief Scientific Officer	A Award deriv	2020-03-09	2020-03-11	7,701	—	$0	7,701	SEC↗
Stuart Iain	Chief Scientific Officer	A Award deriv	2020-03-09	2020-03-11	23,696	—	$0	23,696	SEC↗
Wiley Matthew T.	Chief Commercial Officer	A Award deriv	2020-03-09	2020-03-11	59,240	—	$0	59,240	SEC↗
Wiley Matthew T.	Chief Commercial Officer	A Award deriv	2020-03-09	2020-03-11	57,086	—	$0	57,086	SEC↗
Basta Steven L	Director	A Award	2020-03-09	2020-03-11	7,108	—	$0	522,038	SEC↗
Bruno Anthony D	Director	A Award	2020-03-09	2020-03-11	7,321	—	$0	44,433	SEC↗
Bruno Anthony D	Director	A Award	2020-03-09	2020-03-11	37,112	—	$0	37,112	SEC↗
Domzalski David	President and CEO	A Award	2020-03-09	2020-03-11	138,102	—	$0	191,952	SEC↗
Domzalski David	President and CEO	A Award	2020-03-09	2020-03-11	53,850	—	$0	53,850	SEC↗
Hadar Ilan	CFO and Country Manager	A Award	2020-03-09	2020-03-11	69,012	—	$0	77,351	SEC↗
Hadar Ilan	CFO and Country Manager	A Award	2020-03-09	2020-03-11	8,339	—	$0	8,339	SEC↗
Harsch Mutya	Chief Legal Officer and GC	A Award	2020-03-09	2020-03-11	50,643	—	$0	58,191	SEC↗
Harsch Mutya	Chief Legal Officer and GC	A Award	2020-03-09	2020-03-11	7,548	—	$0	7,548	SEC↗
Hirsch Stanley	Director	A Award	2020-03-09	2020-03-11	108,113	—	$0	108,113	SEC↗
Hirsch Stanley	Director	A Award	2020-03-09	2020-03-11	31,303	—	$0	31,303	SEC↗
Hirsch Stanley	Director	A Award	2020-03-09	2020-03-11	34,960	—	$0	66,263	SEC↗
Stuart Iain	Chief Scientific Officer	A Award	2020-03-09	2020-03-11	7,306	—	$0	7,306	SEC↗
Stuart Iain	Chief Scientific Officer	A Award	2020-03-09	2020-03-11	54,086	—	$0	61,392	SEC↗
Wiley Matthew T.	Chief Commercial Officer	A Award	2020-03-09	2020-03-11	46,680	—	$0	67,576	SEC↗
Wiley Matthew T.	Chief Commercial Officer	A Award	2020-03-09	2020-03-11	20,896	—	$0	20,896	SEC↗
Basta Steven L	Chief Executive Officer	M Exercise deriv	2019-12-11	2019-12-13	14,000	$1.83	$25.6K	357,641	SEC↗
Basta Steven L	Chief Executive Officer	M Exercise deriv	2019-12-11	2019-12-13	238,800	—	$0	0	SEC↗
Krasnow Ronald A.	See Remarks	M Exercise deriv	2019-12-11	2019-12-13	24,090	—	$0	0	SEC↗
Basta Steven L	Chief Executive Officer	M Exercise deriv	2019-12-11	2019-12-16	238,800	—	$0	0	SEC↗
Basta Steven L	Chief Executive Officer	M Exercise deriv	2019-12-11	2019-12-16	14,000	$1.83	$25.6K	357,641	SEC↗
Kwon Paul	Chief Scientific Officer	M Exercise deriv	2019-12-11	2019-12-16	80,300	—	$0	0	SEC↗
BALL KRISTINE M	See Remarks	M Exercise deriv	2019-12-11	2019-12-16	80,300	—	$0	0	SEC↗
Basta Steven L	Chief Executive Officer	M Exercise	2019-12-11	2019-12-13	14,000	$1.83	$25.6K	509,764	SEC↗
Basta Steven L	Chief Executive Officer	M Exercise	2019-12-11	2019-12-13	238,800	—	$0	580,974	SEC↗
Basta Steven L	Chief Executive Officer	F Tax w/h	2019-12-11	2019-12-13	85,210	$4.52	$385.1K	495,764	SEC↗
BALL KRISTINE M	See Remarks	M Exercise	2019-12-11	2019-12-13	80,300	—	$0	80,300	SEC↗
BALL KRISTINE M	See Remarks	F Tax w/h	2019-12-11	2019-12-13	27,766	$4.52	$125.5K	52,534	SEC↗
Krasnow Ronald A.	See Remarks	F Tax w/h	2019-12-11	2019-12-13	8,271	$4.52	$37.4K	15,819	SEC↗
Krasnow Ronald A.	See Remarks	M Exercise	2019-12-11	2019-12-13	24,090	—	$0	24,090	SEC↗
Kwon Paul	Chief Scientific Officer	F Tax w/h	2019-12-11	2019-12-13	27,766	$4.52	$125.5K	52,534	SEC↗
Kwon Paul	Chief Scientific Officer	M Exercise	2019-12-11	2019-12-13	80,300	—	$0	80,300	SEC↗
Basta Steven L	Chief Executive Officer	F Tax w/h	2019-12-11	2019-12-16	85,210	$4.52	$385.1K	495,764	SEC↗
Basta Steven L	Chief Executive Officer	M Exercise	2019-12-11	2019-12-16	238,800	—	$0	580,974	SEC↗
Basta Steven L	Chief Executive Officer	M Exercise	2019-12-11	2019-12-16	14,000	$1.83	$25.6K	509,764	SEC↗
Kwon Paul	Chief Scientific Officer	M Exercise	2019-12-11	2019-12-16	80,300	—	$0	80,300	SEC↗
Kwon Paul	Chief Scientific Officer	F Tax w/h	2019-12-11	2019-12-16	27,766	$4.52	$125.5K	52,534	SEC↗
BALL KRISTINE M	See Remarks	F Tax w/h	2019-12-11	2019-12-16	27,766	$4.52	$125.5K	52,534	SEC↗
BALL KRISTINE M	See Remarks	M Exercise	2019-12-11	2019-12-16	80,300	—	$0	80,300	SEC↗
Kwon Paul	See Remarks	A Award deriv	2019-07-29	2019-07-31	80,300	—	$0	396,812	SEC↗
BALL KRISTINE M	See Remarks	A Award deriv	2019-07-29	2019-07-31	80,300	—	$0	413,423	SEC↗
Basta Steven L	See Remarks	A Award deriv	2019-07-29	2019-07-31	238,800	—	$0	1,050,100	SEC↗
Krasnow Ronald A.	See Remarks	A Award deriv	2019-07-29	2019-07-31	24,090	—	$0	154,090	SEC↗
BALL KRISTINE M	See Remarks	A Award deriv	2019-07-29	2019-08-07	80,300	—	$0	413,423	SEC↗
Kwon Paul	Chief Scientific Officer	A Award deriv	2019-07-29	2019-08-07	80,300	—	$0	396,812	SEC↗
Basta Steven L	Chief Executive Officer	A Award deriv	2019-07-29	2019-08-07	238,800	—	$0	1,050,100	SEC↗
MCGIRR DAVID W J	Director	A Award deriv	2019-06-25	2019-08-08	22,500	—	$0	65,780	SEC↗
Whitcup Scott M	Director	A Award deriv	2019-06-25	2019-08-08	22,500	—	$0	134,099	SEC↗
BERNS PAUL L	Director	A Award deriv	2019-06-25	2019-08-08	22,500	—	$0	65,780	SEC↗
Royston Aaron	Director	A Award deriv	2019-06-25	2019-08-08	22,500	—	$0	22,500	SEC↗
Ebel Ted	Director	A Award deriv	2019-06-25	2019-08-08	22,500	—	$0	53,423	SEC↗
Sandoval Elisabeth	Director	A Award deriv	2019-06-25	2019-06-27	11,645	—	$0	45,000	SEC↗
MCGIRR DAVID W J	Director	A Award deriv	2019-06-25	2019-06-27	22,500	—	$0	65,780	SEC↗
Ebel Ted	Director	A Award deriv	2019-06-25	2019-06-27	22,500	—	$0	53,423	SEC↗
Whitcup Scott M	Director	A Award deriv	2019-06-25	2019-06-27	22,500	—	$0	134,099	SEC↗
BERNS PAUL L	Director	A Award deriv	2019-06-25	2019-06-27	22,500	—	$0	65,780	SEC↗
Royston Aaron	Director	A Award deriv	2019-06-25	2019-06-27	22,500	—	$0	22,500	SEC↗
Krasnow Ronald A.	See Remarks	A Award deriv	2019-06-17	2019-06-27	130,000	—	$0	130,000	SEC↗
Sandoval Elisabeth	Director	A Award deriv	2019-03-19	2019-03-21	33,355	—	$0	33,355	SEC↗
Whitcup Scott M	Director	M Exercise deriv	2019-01-14	2019-01-15	25,000	$1.83	$45.8K	77,043	SEC↗
BALL KRISTINE M	SVP, Corporate Strategy & CF	A Award deriv	2018-12-10	2018-12-12	96,000	—	$0	96,000	SEC↗
Basta Steven L	Chief Executive Officer	A Award deriv	2018-12-10	2018-12-12	141,900	—	$0	141,900	SEC↗
Kwon Paul	Chief Scientific Officer	A Award deriv	2018-12-10	2018-12-12	64,000	—	$0	64,000	SEC↗
Spellman Mary	Chief Medical Officer	A Award deriv	2018-12-10	2018-12-12	96,000	—	$0	96,000	SEC↗
Watson James F	Other	S Sale	2018-07-24	2018-07-26	487,500	$7.65	$3.73M	1,907,568	SEC↗
Watson James F	Other	S Sale	2018-07-24	2018-07-26	12,500	$7.65	$95.6K	48,910	SEC↗
Basta Steven L	Chief Executive Officer	A Award deriv	2018-05-03	2018-05-04	212,850	—	$0	669,400	SEC↗
BALL KRISTINE M	See Remarks	A Award deriv	2018-05-03	2018-05-04	64,000	—	$0	237,123	SEC↗
Kwon Paul	Chief Medical Officer	A Award deriv	2018-05-03	2018-05-04	64,000	—	$0	252,512	SEC↗
Presidio Partners 2007 (Parall	10% Owner	J Other	2018-03-02	2018-07-26	152,062	—	$0	152,062	SEC↗
Cha Albert	Director	C Conversion deriv	2018-01-29	2018-01-29	6,335,215	—	$0	0	SEC↗
Cha Albert	Director	C Conversion deriv	2018-01-29	2018-01-29	874,817	—	$0	0	SEC↗
Cha Albert	Director	C Conversion deriv	2018-01-29	2018-01-29	341,784	—	$0	0	SEC↗
Cha Albert	Director	C Conversion deriv	2018-01-29	2018-01-29	2,475,118	—	$0	0	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	6,335,215	—	$0	0	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	874,817	—	$0	0	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	2,475,118	—	$0	0	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	341,784	—	$0	0	SEC↗
Remeditex Ventures LLC	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	821,596	—	$0	0	SEC↗
Remeditex Ventures LLC	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	2,351,097	—	$0	0	SEC↗
Remeditex Ventures LLC	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	7,150	—	$0	0	SEC↗
venBio Global Strategic Fund I	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	3,227,700	—	$0	0	SEC↗
Collier David J	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	179	—	$0	0	SEC↗
Collier David J	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	6,971	—	$0	0	SEC↗
Collier David J	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	2,292,320	—	$0	0	SEC↗
Collier David J	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	58,777	—	$0	0	SEC↗
Collier David J	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	343,310	—	$0	0	SEC↗
Collier David J	10% Owner	C Conversion deriv	2018-01-29	2018-01-29	21,789	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2018-01-29	2018-01-31	821,596	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2018-01-29	2018-01-31	2,194,357	—	$0	0	SEC↗
Cha Albert	Director	C Conversion	2018-01-29	2018-01-29	324,306	—	$0	359,992	SEC↗
Cha Albert	Director	C Conversion	2018-01-29	2018-01-29	2,348,550	—	$0	2,606,982	SEC↗
Cha Albert	Director	C Conversion	2018-01-29	2018-01-29	126,703	—	$0	486,695	SEC↗
Cha Albert	Director	C Conversion	2018-01-29	2018-01-29	917,559	—	$0	3,524,541	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion	2018-01-29	2018-01-29	126,703	—	$0	486,695	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion	2018-01-29	2018-01-29	917,559	—	$0	3,524,541	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion	2018-01-29	2018-01-29	324,306	—	$0	359,992	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion	2018-01-29	2018-01-29	2,348,550	—	$0	2,606,982	SEC↗
Remeditex Ventures LLC	10% Owner	C Conversion	2018-01-29	2018-01-29	304,576	—	$0	2,761,663	SEC↗
Remeditex Ventures LLC	10% Owner	C Conversion	2018-01-29	2018-01-29	871,583	—	$0	2,457,087	SEC↗
Remeditex Ventures LLC	10% Owner	C Conversion	2018-01-29	2018-01-29	2,650	—	$0	1,585,504	SEC↗
venBio Global Strategic Fund I	10% Owner	C Conversion	2018-01-29	2018-01-29	1,196,552	—	$0	1,461,552	SEC↗
Collier David J	10% Owner	C Conversion	2018-01-29	2018-01-29	3,263	—	$0	61,410	SEC↗
Collier David J	10% Owner	C Conversion	2018-01-29	2018-01-29	2,584	—	$0	1,418,005	SEC↗
Collier David J	10% Owner	C Conversion	2018-01-29	2018-01-29	127,269	—	$0	2,395,068	SEC↗
Collier David J	10% Owner	C Conversion	2018-01-29	2018-01-29	21,789	—	$0	58,147	SEC↗
Collier David J	10% Owner	C Conversion	2018-01-29	2018-01-29	849,794	—	$0	2,267,799	SEC↗
Collier David J	10% Owner	C Conversion	2018-01-29	2018-01-29	66	—	$0	36,358	SEC↗
FMR LLC	Other	C Conversion	2018-01-29	2018-01-31	813,478	—	$0	813,478	SEC↗
FMR LLC	Other	C Conversion	2018-01-29	2018-01-31	304,576	—	$0	1,118,054	SEC↗
Cha Albert	Director	P Buy	2018-01-25	2018-01-29	258,432	$17.00	$4.39M	258,432	SEC↗
Cha Albert	Director	P Buy	2018-01-25	2018-01-29	35,686	$17.00	$606.7K	35,686	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	P Buy	2018-01-25	2018-01-29	35,686	$17.00	$606.7K	35,686	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	P Buy	2018-01-25	2018-01-29	258,432	$17.00	$4.39M	258,432	SEC↗
Remeditex Ventures LLC	10% Owner	P Buy	2018-01-25	2018-01-29	100,000	$17.00	$1.70M	1,582,854	SEC↗
venBio Global Strategic Fund I	10% Owner	P Buy	2018-01-25	2018-01-29	265,000	$17.00	$4.50M	265,000	SEC↗